Matters of the heart: assessing the cardiovascular safety of new drugs

Am Heart J. 2003 Oct;146(4):561-2. doi: 10.1016/S0002-8703(03)00400-9.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Cardiovascular Diseases / chemically induced
  • Clinical Trials as Topic
  • Cyclooxygenase Inhibitors / adverse effects*
  • Gastrointestinal Diseases / chemically induced
  • Gastrointestinal Diseases / prevention & control
  • Humans
  • Lactones / adverse effects*
  • Sulfones
  • Thrombosis / chemically induced*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase Inhibitors
  • Lactones
  • Sulfones
  • rofecoxib